{"id":786756,"date":"2023-09-28T10:07:56","date_gmt":"2023-09-28T14:07:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/"},"modified":"2023-09-28T10:07:56","modified_gmt":"2023-09-28T14:07:56","slug":"lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/","title":{"rendered":"Lisata Therapeutics Announces Participation in Upcoming Conferences in October"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BASKING RIDGE, N.J., Sept.  28, 2023  (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present at two upcoming conferences in October. Details of the events are as follows:<\/p>\n<p>\n        <strong><br \/>\n          <em>BioCentury-BayHelix East-West Biopharma Summit<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>October 2-4 | Cambridge, MA<\/p>\n<p>Dr. Mazzo will deliver a live presentation on Tuesday, October 3, 2023 at 10:15 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors that day. For more information about the East-West Biopharma Summit, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OpYAt2rxycuhV4ksPvrISd9Ud3HVt5_q0MbHJta1o8N18RywkEQu-BeqZrFktO1k00nFhD2Tg6R7P6ne_0HWzrBF5yvioJwOSGTTS40eEqwhN9Mqeruxh032deIum0VsMjQ3KwQGM06TP1tfPdZ_LxuIkR4Mjy1psubIMvIpvyU=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/conferences.biocentury.com\/east-west-summit<\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <em>BioFuture <\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>October 4-6 | New York City, NY<\/p>\n<p>Dr. Mazzo will deliver a live presentation on Thursday, October 5, 2023 at 10:00 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors that day. For more information about BioFuture, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OpYAt2rxycuhV4ksPvrISSuEEeEB4UM2iPp4vfuE_CQUk-MRzzMAAiYOyHddSp_H6CanEikiCi58Y13u9uSHv-bYobPiCA99hvflqSGuxg4=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/biofuture.com\/<\/a>.<\/p>\n<p>\n        <strong>About Lisata Therapeutics<\/strong>\n      <\/p>\n<p>Lisata Therapeutics is a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F1JQ5ojB-cfK2gcXrZJPRLFhs7RL4Aa4ejgpqly4QcnX58Hdz5pEnrZnkjeUGHujGYy-F7SBhAJuGuGSeYV9agPj2Lyb7f5lf3-Xx9dMtUrAPBXFokDYh2IDUrG8R1H2Ji5kPcr-_Il2v8IzvjxIW8FhWMeRyeEXOBFVXamP5Yg=\" rel=\"nofollow noopener\" target=\"_blank\">clinical-stage pharmaceutical company<\/a> dedicated to the discovery, development and commercialization of innovative therapies for the treatment of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-QvI-vgpKw9abBhks-j0Kn4KjUwcZ7ptVgBhAiOwddgI_kVWXZL8F0nXS9HYkEAPtc2dguRyvFRNElA91MFMKyUorVFK1kX6DsnzKginMyYhnhPddQ4RkxzY5ubo7NncuYlCTEjQLgYiRk12KXg5aQ==\" rel=\"nofollow noopener\" target=\"_blank\">advanced solid tumors<\/a> and other major diseases. Lisata\u2019s lead product candidate, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=65-EBNIhwOgkKIn74oMfPLNrd7LiuB2vUA5a1oPQWglKlOAkC2-vhTgVBfmgDW7XAB-eEpYvwF4wJHzluLxrVIw1P-4vEDs_39rpoOFliKB9D7VzhWNWTGrKSL0_NPBM_Y5sGq_Fao16bAYijciek0gllwO7kg1eYYSZjGdIHXI=\" rel=\"nofollow noopener\" target=\"_blank\">LSTA1<\/a>, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate solid tumors more effectively. Based on Lisata\u2019s CendR Platform\u00ae Technology, Lisata has already established noteworthy commercial and R&amp;D partnerships. The Company expects to announce numerous clinical study and business milestones over the next two years and has projected that its current business and development plan is funded with available capital through these milestones and into early 2026. For more information on the Company, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MhV4nQ-n8ZmqRovVUakZ99-XgPnRo8ZrAGt2hbUk3LGMAXo3n14JeQBEZ3MB080J4UuMnENrTw1HmwN6iy3OXw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.lisata.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Investors and Media:<\/p>\n<p>Lisata Therapeutics, Inc.<br \/>John Menditto<br \/>Vice President, Investor Relations and Corporate Communications<br \/>Phone:\u00a0908-842-0084<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hpuriklkCe3vjV2gVqfepGmgBlW0rGk1vHJwAwoqU-D8GrYlP0M_1qTWceXO5oKHjt-P8A_l8EBP2kBVBAf4rOUQRnyAzTQCNj9IveiCCvk=\" rel=\"nofollow noopener\" target=\"_blank\">jmenditto@lisata.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MGRiZTViODktYWYxMi00OGM3LWFiMDYtZTQwMmRmNDIzZjU5LTEwMzI4NjY=\/tiny\/Lisata-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BASKING RIDGE, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present at two upcoming conferences in October. Details of the events are as follows: BioCentury-BayHelix East-West Biopharma Summit October 2-4 | Cambridge, MA Dr. Mazzo will deliver a live presentation on Tuesday, October 3, 2023 at 10:15 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors that day. For more information about the East-West Biopharma Summit, please visit https:\/\/conferences.biocentury.com\/east-west-summit. BioFuture October 4-6 | New York City, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lisata Therapeutics Announces Participation in Upcoming Conferences in October&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-786756","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lisata Therapeutics Announces Participation in Upcoming Conferences in October - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lisata Therapeutics Announces Participation in Upcoming Conferences in October - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BASKING RIDGE, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present at two upcoming conferences in October. Details of the events are as follows: BioCentury-BayHelix East-West Biopharma Summit October 2-4 | Cambridge, MA Dr. Mazzo will deliver a live presentation on Tuesday, October 3, 2023 at 10:15 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors that day. For more information about the East-West Biopharma Summit, please visit https:\/\/conferences.biocentury.com\/east-west-summit. BioFuture October 4-6 | New York City, &hellip; Continue reading &quot;Lisata Therapeutics Announces Participation in Upcoming Conferences in October&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-28T14:07:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lisata Therapeutics Announces Participation in Upcoming Conferences in October\",\"datePublished\":\"2023-09-28T14:07:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/\"},\"wordCount\":315,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/\",\"name\":\"Lisata Therapeutics Announces Participation in Upcoming Conferences in October - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=\",\"datePublished\":\"2023-09-28T14:07:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lisata Therapeutics Announces Participation in Upcoming Conferences in October\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lisata Therapeutics Announces Participation in Upcoming Conferences in October - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/","og_locale":"en_US","og_type":"article","og_title":"Lisata Therapeutics Announces Participation in Upcoming Conferences in October - Market Newsdesk","og_description":"BASKING RIDGE, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present at two upcoming conferences in October. Details of the events are as follows: BioCentury-BayHelix East-West Biopharma Summit October 2-4 | Cambridge, MA Dr. Mazzo will deliver a live presentation on Tuesday, October 3, 2023 at 10:15 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors that day. For more information about the East-West Biopharma Summit, please visit https:\/\/conferences.biocentury.com\/east-west-summit. BioFuture October 4-6 | New York City, &hellip; Continue reading \"Lisata Therapeutics Announces Participation in Upcoming Conferences in October\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-28T14:07:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lisata Therapeutics Announces Participation in Upcoming Conferences in October","datePublished":"2023-09-28T14:07:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/"},"wordCount":315,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/","name":"Lisata Therapeutics Announces Participation in Upcoming Conferences in October - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=","datePublished":"2023-09-28T14:07:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDIxNCM1ODM3MTEyIzIwMjExNTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-october\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lisata Therapeutics Announces Participation in Upcoming Conferences in October"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/786756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=786756"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/786756\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=786756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=786756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=786756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}